Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment.

Source:http://linkedlifedata.com/resource/pubmed/id/2268980

Download in:

View as

General Info

PMID
2268980